Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load
- 16 June 2016
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 374 (24), 2324-2334
- https://doi.org/10.1056/nejmoa1508660
Abstract
Few data are available regarding the use of tenofovir disoproxil fumarate (TDF) during pregnancy for the prevention of mother-to-child transmission of hepatitis B virus (HBV).Keywords
This publication has 28 references indexed in Scilit:
- Positive hepatitis B surface antigen tests due to recent vaccination: a persistent problemBMC Clinical Pathology, 2012
- An Algorithm for Risk Assessment and Intervention of Mother to Child Transmission of Hepatitis B VirusClinical Gastroenterology and Hepatology, 2012
- Concentrations of Tenofovir and Emtricitabine in Breast Milk of HIV-1-Infected Women in Abidjan, Côte d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2Antimicrobial Agents and Chemotherapy, 2011
- New perspectives for hepatitis B vaccines and immunizationVaccine, 2009
- Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double‐blind, placebo‐controlled studyJournal of Viral Hepatitis, 2009
- A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 UpdateClinical Gastroenterology and Hepatology, 2008
- Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis BThe New England Journal of Medicine, 2008
- Natural History and Clinical Consequences of Hepatitis B Virus InfectionInternational Journal of Medical Sciences, 2005
- Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonatesJournal of Hepatology, 1994
- TRANSMISSION OF HEPATITIS B ANTIGENS FROM SYMPTOM FREE CARRIER MOTHERS TO THE FETUS AND THE INFANTBJOG: An International Journal of Obstetrics and Gynaecology, 1980